background
first
introduc
recombinas
polymeras
amplif
rpa
stir
great
interest
evidenc
public
octob
last
year
widespread
adopt
isotherm
molecular
tool
mani
diagnost
field
repres
afford
approxim
usd
per
test
simpl
easi
handson
step
fast
result
within
min
sensit
singl
target
copi
number
detect
method
identif
pathogen
detect
singl
nucleotid
polymorph
human
cancer
genet
modifi
organ
content
review
summar
current
knowledg
rpa
molecular
diagnost
variou
rnadna
pathogen
discuss
highlight
recent
applic
clinic
set
focu
pointofcar
poc
bioassay
autom
fluidic
platform
strength
limit
isotherm
method
also
address
summari
rpa
becom
molecular
tool
choic
rapid
specif
costeffect
identif
pathogen
owe
minim
sampleprepar
requir
low
oper
temperatur
commerci
avail
freezedri
reagent
method
appli
outsid
laboratori
set
remot
area
interestingli
onboard
autom
sampletoansw
microfluid
devic
rpa
undoubtedli
promis
isotherm
molecular
techniqu
clinic
microbiolog
laboratori
emerg
respons
clinic
set
last
decad
remark
increas
develop
adapt
novel
exist
isotherm
amplif
technolog
molecular
diagnost
dozen
isotherm
technolog
differ
respect
enzymat
mechan
known
recent
review
elsewher
review
focu
recombinas
polymeras
amplif
rpa
simplic
easi
handson
manipul
flexibl
differ
commerci
kit
format
offer
variou
detect
method
dna
rna
speed
result
min
rpa
entail
primer
probe
option
simpl
design
requir
dna
unwind
primer
anneal
rpa
use
recombinas
enzym
accessori
protein
rpa
high
specif
effici
fold
amplif
min
display
complet
isotherm
profil
requir
addit
temperatur
step
dna
denatur
rpa
reagent
avail
dri
format
henc
facilit
applic
diagnost
consequ
rpa
technolog
increasingli
use
differ
field
result
remark
output
public
paper
avail
pubm
publish
last
year
see
fig
data
supplement
accompani
onlin
version
review
http
summar
discuss
current
knowledg
technolog
focus
recent
diagnost
applic
rpa
work
rpa
compris
key
protein
substitut
usual
heat
denatur
step
pcr
escherichia
coli
reca
recombinas
singlestrand
dna
bind
protein
ssb
replic
perform
dna
polymeras
stranddisplac
activ
necessari
extend
primer
current
commerci
kit
use
saudna
polymeras
staphylococcu
aureu
accessori
protein
cofactor
also
support
rpa
reaction
process
uvsi
protein
recombinas
load
factor
assist
reca
format
nucleoprotein
filament
polyethylen
glycol
macromolecul
high
molecular
weight
shown
stimul
interact
rpa
key
protein
dna
act
crowd
agent
creatin
kinas
use
phosphocreatin
gener
atp
fuel
enzym
system
composit
use
typic
rpa
kit
altern
compon
describ
instanc
reca
could
replac
uvsx
protein
ssb
protein
sau
polymeras
bsu
polymeras
polyethylen
glycol
replac
rpa
recombinas
assist
load
factor
form
nucleoprotein
filament
singlestrand
oligonucleotid
primer
probe
filament
scan
doublestrand
dna
dsdna
target
search
homolog
sequenc
homolog
found
filament
invad
dsdna
form
dloop
structur
local
separ
dna
strand
complementari
strand
stabil
ssb
target
strand
hybrid
primer
fig
recombinas
disassembl
nucleoprotein
filament
induc
reca
protein
hydrolyz
atp
allow
primer
elong
stranddisplac
dna
polymeras
newli
gener
dna
strand
use
anoth
round
rpa
consequ
exponenti
amplif
accomplish
repeat
rpa
cycl
describ
selfperpetu
exhaust
phosphocreatin
pool
typic
rpa
reaction
execut
singl
temperatur
min
depend
start
templat
copi
number
amplicon
size
addit
possibl
amplifi
rna
target
incorpor
revers
transcriptas
rpa
reagent
compon
reversetranscriptas
rpa
rtrpa
oper
singl
temperatur
exo
rt
basic
rt
kit
respect
still
enabl
target
detect
min
rpa
current
commerci
research
use
twistdx
kit
configur
enabl
dna
rna
amplif
detect
amplif
product
visual
agaros
gel
electrophoresi
later
flow
strip
realtim
fluoresc
probe
tabl
typic
rpa
kit
compris
individu
tube
contain
lyophil
rpa
reagent
pellet
reaction
buffer
magnesium
acet
control
posit
control
dna
control
primer
probe
possibl
incorpor
targetspecif
rpa
primersprob
lyophil
rpa
reagent
pellet
rpa
kit
store
month
use
rpa
experiment
protocol
necessit
simpl
handson
manipul
reaction
solut
form
mix
rpa
primer
andor
probe
buffer
solut
target
nucleic
acid
mixtur
ad
directli
lyophil
rpa
reagent
pellet
follow
brief
mix
centrifug
step
reaction
initi
ad
magnesium
incub
perform
singl
temperatur
rang
depend
kit
use
tabl
incub
detect
rpa
product
either
perform
real
time
reaction
realtim
detect
result
obtain
incub
stage
typic
min
postrpa
detect
agaros
gel
electrophoresi
use
rpa
amplicon
must
first
purifi
separ
gel
lateralflow
detect
rpa
amplicon
use
directli
without
purif
gener
result
dipstick
strip
within
min
postrpa
accord
manufactur
guidelin
rpa
primer
probe
design
rpa
primer
base
long
optim
format
recombinas
primer
filament
longer
primer
base
recommend
long
track
one
particular
nucleotid
larg
number
small
repeat
avoid
low
high
gc
content
must
also
avoid
rpa
amplifi
long
sequenc
kb
howev
better
result
obtain
shorter
amplicon
rang
bp
bp
optim
addit
melt
temperatur
requir
rpa
primer
probe
primer
anneal
elong
enzym
mediat
temperatur
driven
realtim
detect
kind
probe
rpaexo
fpg
use
convent
probe
taqman
use
rpa
pcr
taq
polymeras
compat
amplif
system
either
exonucleas
activ
taq
polymeras
progress
digest
displac
strand
strand
displac
process
thu
inhibit
dna
amplif
explain
use
strand
displac
polymeras
rpa
exonucleas
activ
requir
taqman
probe
detect
eg
bsudna
polymeras
exo
probe
long
oligonucleotid
base
bear
intern
base
analog
eg
tetrahydrofuran
thf
locat
fluorophor
eg
fam
tamra
quencher
eg
black
hole
quencher
black
hole
quencher
block
end
eg
phosphat
group
dideoxynucleotid
abas
residu
serv
substrat
e
coli
exonucleas
iii
cleav
thf
bind
probe
target
sequenc
thu
separ
fluorophor
quencher
fig
fluoresc
gener
typic
yield
detect
signal
within
min
rpa
reaction
note
exonucleas
cleavag
gener
free
exo
probe
extend
polymeras
enzym
serv
forward
primer
compar
exo
probe
fpg
probe
shorter
base
core
protein
recombinas
ssb
stranddisplac
polymeras
enabl
exponenti
dna
amplif
without
need
thermal
cycl
initi
chemic
thermal
melt
step
complet
reaction
perform
singl
temperatur
depend
rpa
kit
formul
serv
primer
quencher
fluorophor
base
downstream
attach
ribos
abas
nucleotid
via
coc
linker
herein
deoxyribos
dr
fluorophor
fpg
dna
glycosylas
catalyt
mode
differ
exonucleas
iii
recogn
cleav
drfluorophor
leav
nonextend
sequenc
fig
postrpa
later
flow
lf
detect
use
nfo
kit
design
lfprobe
requir
tag
ie
fam
thf
residu
e
coli
endonucleas
iv
nfo
recognit
cleavag
thu
serv
primer
similar
exo
probe
fig
therefor
nfo
endonucleas
replac
exonucleas
iii
recogn
substrat
ie
thf
residu
howev
nfo
gener
lower
signal
incomplet
cleavag
limit
degrad
amplicon
allow
amplicon
detect
gel
electrophoresi
option
possibl
use
exo
probe
later
flow
assay
revers
primer
oppos
amplif
primer
label
form
label
nfo
probe
doubl
label
amplicon
captur
speciesspecif
antifam
antibodi
coupl
gold
nanoparticl
anoth
immobil
antibodi
captur
biotin
thu
form
detect
line
commerci
avail
strip
mghd
twistdx
control
line
immobil
antispeci
antibodi
serv
monitor
later
flow
process
fig
analyz
total
rpa
primer
probe
exo
fpg
nfo
probe
sequenc
origin
publish
rpa
articl
observ
author
succeed
use
rpa
primersprob
present
differ
manufactur
guidelin
instanc
rpa
primer
base
base
long
base
short
sequenc
base
use
studi
primer
also
serv
captur
probe
ten
percent
primer
sequenc
content
content
publish
exo
probe
sequenc
exo
probe
shorter
recommend
length
base
instead
base
base
long
small
proport
exo
probe
content
probe
consid
review
use
exo
probe
realtim
detect
method
rather
fpg
nfo
probe
therefor
consid
discrep
data
fpg
nfo
probe
repres
exo
probe
see
onlin
supplement
fig
rpa
success
use
detect
major
human
pathogen
includ
bacteria
virus
fungi
parasit
well
genet
modifi
organ
genet
alter
observ
cancer
cell
rpa
also
use
hiv
diagnosi
lowresourc
set
tabl
analyt
limit
detect
turnaround
time
vari
assay
rna
detect
copi
target
detect
min
copi
min
dna
detect
copi
detect
min
copi
detect
min
suggest
rpa
effici
could
depend
target
sequenc
amplicon
size
type
biolog
sampl
test
demonstr
fpg
probe
less
sensit
target
molecul
detect
exo
probe
assay
target
molecul
detect
suggest
fpg
nucleas
slower
kinet
realtim
detect
exonucleas
iii
explain
prefer
use
realtim
exo
kit
advantag
fpg
exo
kit
fact
former
allow
detect
agaros
gel
electrophoresi
rna
detect
sever
group
use
exo
rt
kit
contain
murin
leukemia
viru
mulv
rt
lyophil
pellet
mixtur
rtrpa
assay
sensit
rang
target
copi
min
tabl
also
design
rna
detect
assay
use
kit
exo
rt
kit
detect
rna
transcript
influenza
viru
presenc
pool
nasopharyng
swab
sampl
combin
differ
nasopharyng
sampl
neg
influenza
viru
obtain
limit
detect
rna
copi
ci
vs
rna
copi
ci
without
sampl
respect
case
copi
rna
transcript
detect
min
thu
correl
result
studi
see
onlin
supplement
tabl
group
success
ad
transcriptor
revers
transcriptas
roch
molecular
diagnost
twistamp
exo
kit
reagent
mixtur
rtrpa
euler
et
al
first
evalu
differ
rt
enzym
rpa
reagent
demonstr
transcriptor
rt
perform
better
mulv
rt
molecul
detect
transcriptor
rt
vs
molecul
mulv
rt
sensiscript
rt
qiagen
molecul
detect
combin
exo
kit
assay
detect
rift
valley
fever
viru
anoth
studi
also
report
reduc
perform
mulv
rt
compar
transcriptor
assay
detect
rna
extract
footandmouth
diseas
viru
sampl
sensit
mulv
rtbase
rtrpa
sensit
rtrpa
use
transcriptor
rt
attempt
compar
perform
mulv
rt
transcriptor
rt
obtain
similar
rt
enzym
perform
copi
influenza
rna
transcript
detect
min
mulv
rt
compar
min
transcriptor
rt
similar
fluoresc
signal
intens
afu
see
onlin
supplement
fig
therefor
seem
rpa
could
use
differ
rt
enzym
howev
yet
public
use
rtrpa
quantit
rna
measur
rpa
demonstr
certain
toler
common
pcr
inhibitor
shown
oper
nucleic
acid
extract
variou
sampl
matric
blood
serum
fecal
nasal
vagin
swab
plasma
foodstuff
plant
anim
tissu
milk
stool
urin
instanc
rpa
abl
function
presenc
milk
mmoll
maximum
concentr
toler
pcr
rpa
method
amplifi
target
even
presenc
gl
hemoglobin
vol
vol
ethanol
u
heparin
serum
howev
rpa
inhibit
whole
blood
previou
studi
evalu
toler
rpa
differ
type
clinic
sampl
includ
stool
sampl
briefli
differ
volum
dilut
stool
sampl
l
stool
dilut
l
te
buffer
mmoll
tri
ph
hcl
mmoll
edta
rang
l
inocul
genom
copi
streptococcu
agalactia
genom
dna
amplifi
exo
kit
rpa
still
effici
l
stool
sampl
ad
ie
reaction
volum
signific
inhibit
result
gener
min
henc
suggest
appropri
sampl
prepar
direct
rpa
amplif
detect
crude
sampl
may
feasibl
instanc
consolid
sampl
prepar
nucleic
acid
amplificationdetect
erhchia
colleagu
abl
detect
methicillinresist
staphylococcu
aureu
mrsa
dna
directli
spike
blood
sampl
process
consist
inerti
plasma
separ
avoid
red
blood
cell
lysi
therebi
elimin
potenti
pcrinhibitor
hemoglobin
system
prove
separ
effici
ultim
best
sampl
prepar
approach
adjust
type
applic
consid
mani
factor
target
concentr
presenc
inhibitor
lysi
effici
design
spike
biolog
sampl
b
rt
realtim
exo
kit
lf
later
flow
nfo
kit
ag
agaros
gel
electrophoresi
basic
kit
c
valu
indic
simplex
assay
primer
probe
report
sensit
fg
estim
contain
equival
singl
bacteri
cell
report
sensit
fg
genom
dna
estim
contain
equival
parasit
per
reaction
e
nd
determin
howev
report
sensit
cfuml
cleotid
sequenc
onto
solidsupport
conduct
either
prerpa
amplif
surfac
rpa
amplif
exampl
hybrid
assay
perform
microtit
plate
ie
rpaelisa
sandwich
assay
use
aptam
novel
solidphas
platform
eg
dvd
epoxi
silan
silicon
micror
surfac
rpa
combin
elisa
food
safeti
analysi
test
detect
allergen
genet
modifi
organ
bacteria
fungi
rpaelisa
perform
well
pcrelisa
show
similar
sensit
g
analyteg
food
rpaelisa
compar
g
analyt
per
gram
food
pcrelisa
assay
reproduc
rpaelisa
compar
pcrelisa
howev
hybrid
assay
elisa
test
fastidi
requir
sever
optim
eg
probe
antibodi
concentr
hybrid
temperatur
time
reaction
volum
furthermor
typic
involv
multipl
amplicon
treatment
step
take
least
minpost
rpa
yield
signal
detect
rpa
amplif
perform
dvd
surfac
food
analysi
analyt
sensit
copiesml
copiesml
sever
factor
influenc
effici
robust
amplif
instanc
evapor
problem
must
reduc
liquid
volum
incub
temperatur
concentr
bound
unbound
primer
volum
solut
surfac
reaction
product
must
care
determin
platform
still
research
use
yet
commerci
avail
also
lack
autom
ie
sever
handson
manipul
onchip
sampl
prepar
process
carri
risk
crosscontamin
due
absenc
closedtub
assay
although
extrem
fast
pcr
timetoresult
min
describ
procedur
reli
sophist
instrument
allow
fast
pcr
cycl
scycl
instead
scycl
fast
heat
transfer
thu
consum
high
power
match
fast
instrument
kinet
primer
polymeras
concentr
must
increas
thu
substanti
rais
assay
cost
princip
advantag
behind
microfluid
integr
nucleic
acid
amplif
technolog
possibl
autom
biolog
step
requir
sampl
prepar
nucleic
acid
amplif
detect
autom
result
shorten
turnaround
time
reduc
volum
sampl
reagent
minim
handl
step
enhanc
assay
throughput
costeffici
integr
system
may
render
molecular
assay
amen
pointofcar
poc
analysi
close
possibl
patient
sever
studi
aim
bring
test
poc
integr
rpa
miniatur
simpl
devic
lutz
et
al
first
integr
rpa
exo
centrifug
microfluid
cartridg
contain
prestor
liquid
dri
rpa
reagent
rapid
detect
mrsa
min
cartridg
allow
conduct
parallel
rpa
reaction
disc
contain
chamber
caviti
chamber
prestor
lyophil
rpa
reagent
realtim
detect
use
exo
probe
perform
fluoresc
measur
perform
adjust
rotorgen
instrument
system
proofofprincipl
valid
clinic
sampl
type
microfluid
platform
also
use
rpa
paper
plastic
platform
design
hiv
diagnosi
platform
differ
previous
mention
microfluid
devic
made
simpl
inexpens
userfriendli
materi
pump
requir
system
abl
perform
mani
function
microfluid
devic
paper
plastic
devic
function
mix
reagent
simpl
diffus
fold
platform
detect
hiv
dna
made
use
later
flow
strip
report
detect
limit
copi
within
min
anoth
studi
platform
serv
diagnosi
cryptosporidiosi
stool
sampl
infect
sampl
detect
despit
simplic
howev
potenti
risk
contamin
handl
done
open
system
sampl
prepar
later
flow
detect
integr
reagent
manual
dispens
avoid
nonspecif
preamplif
reaction
potenti
amplicon
crosscontamin
rpa
reagent
compartment
separ
well
slipchip
could
assembl
slide
plate
togeth
digit
rpa
slipchip
platform
allow
perform
quantit
analysi
endpoint
fluoresc
measur
realtim
detect
use
exo
probe
quantif
rpa
also
possibl
compartment
rpa
mixtur
individu
aqueou
microdroplet
centrifug
step
emulsif
listeria
monocytogen
dna
detect
copi
l
quantifi
min
autom
droplet
rpa
also
appli
realtim
detect
antibiot
resist
carbapenemas
produc
e
coli
detect
singl
copi
within
min
previous
mention
platform
whether
portabl
disc
origami
paper
slip
chip
perform
sampletoansw
analysi
lack
integr
sampl
prepar
howev
kim
et
al
develop
sampletoansw
cartridg
abl
perform
sampl
prepar
via
laser
irradi
detect
achiev
integr
lateralflow
strip
cartridg
compos
u
simultan
process
independ
rpa
reaction
workflow
start
initi
manual
load
step
samplerpa
solut
rest
procedur
autom
sampl
prepar
detect
appli
detect
salmonella
spikedmilk
sampl
full
process
achiev
min
limit
detect
cfuml
although
complet
enclos
microfluid
cartridg
offer
rapid
simpl
sampletoansw
procedur
pathogen
screen
commerci
avail
still
need
valid
complex
biolog
sampl
rpa
also
appli
field
outsid
laboratori
set
rna
dna
detect
portabl
suitcases
laboratori
contain
necessari
equip
reagent
develop
perform
normal
benchbas
rpa
test
field
despit
advent
novel
platform
none
commerci
yet
requir
optim
term
instrument
simplif
portabl
costeffect
well
clinic
valid
meet
poc
requir
better
illustr
strength
weak
rpa
among
isotherm
techniqu
made
concis
comparison
rpa
short
list
novel
commonest
isotherm
technolog
see
onlin
supplement
tabl
specif
criteria
taken
consider
turnaround
time
incub
temperatur
complex
primersprob
design
detect
scheme
multiplex
capabl
compat
miniatur
sampl
process
commerci
avail
reagent
amplif
dna
rna
turnaround
time
reflect
speed
isotherm
technolog
gener
result
ideal
speed
test
less
h
incub
temperatur
import
element
associ
complex
instrument
requir
isotherm
amplif
gener
isotherm
technolog
oper
lower
temperatur
eg
therebi
need
less
power
especi
requir
initi
denatur
cycl
step
instanc
among
isotherm
technolog
list
onlin
supplement
tabl
complet
isotherm
techniqu
helicasedepend
amplif
rpa
nick
enzym
amplif
reaction
ribonucleasemedi
amplif
crossprim
amplif
enabl
nucleic
acid
amplif
singl
temperatur
throughout
reaction
thu
allevi
need
temperatur
fluctuat
control
simplifi
instrument
sever
publish
studi
perform
rpa
use
simpl
instrument
oven
heat
block
sodium
sulfat
even
use
exotherm
heat
sourc
rpa
reaction
oper
make
rpa
suitabl
noninstru
nucleic
acid
amplif
platform
demonstr
recent
loopmedi
isotherm
amplif
lamp
technolog
studi
program
assess
technolog
health
research
institut
moreov
capac
rpa
catalyz
nucleic
acid
amplif
use
bodi
heat
also
demonstr
knowledg
rpa
first
isotherm
technolog
demonstr
noninstrument
requir
bodi
heat
import
criteria
poc
applic
addit
stabil
rpa
dri
reagent
allow
transport
storag
without
refriger
mean
broad
rang
end
user
oper
rpa
especi
low
resourc
set
furthermor
primer
probe
design
requir
play
key
role
specif
well
feasibl
multiplex
take
exampl
lamp
primer
recogn
differ
region
target
sequenc
requir
render
amplif
process
highli
specif
hand
isotherm
technolog
requir
certain
particular
primer
probe
design
strand
displac
amplif
nick
enzym
amplif
reaction
requir
short
chimer
primer
contain
dnarna
base
long
base
rpa
primersprob
despit
requir
long
primersprob
rpa
reaction
sever
multiplex
assay
report
moreov
detect
strategi
offer
isotherm
technolog
associ
speed
analysi
complex
instrument
simpl
detect
method
usual
fast
instanc
rpa
offer
sever
detect
strategi
either
realtim
postamplif
realtim
rpa
detect
perform
fluoresc
probe
gener
result
min
closedtub
assay
format
avoid
downstream
crosscontamin
postamplif
detect
method
rpa
use
agaros
gel
electrophoresi
approxim
min
result
lateralflow
strip
min
tabl
contrast
lamp
applic
probebas
detect
method
feasibl
cauliflowerlik
structur
lamp
product
therefor
realtim
lamp
detect
restrict
fluoresc
dye
detect
postamplif
lamp
detect
method
could
reli
nake
eye
turbid
reaction
mixtur
increas
pyrophosph
byproduct
format
howev
endpoint
analysi
gel
electrophoresi
later
flow
turbidimetri
case
helicasedepend
amplif
nucleic
acid
sequencebas
amplif
lamp
result
requir
min
depend
assay
furthermor
lamp
product
yield
ladderlik
pattern
agaros
gel
electrophoresi
wherea
rpapurifi
amplicon
directli
identifi
specif
band
agaros
gel
rpa
speed
could
potenti
exploit
ng
nextgener
sequenc
applic
presequenc
amplif
requir
gener
librari
evalu
rpa
diagnost
perform
clinic
test
involv
comparison
gold
standard
refer
method
instanc
rpa
compar
pcr
andor
wide
use
isotherm
method
lamp
studi
valid
rpa
made
clinic
sampl
vaginalan
lysat
n
clinic
sensit
clinic
specif
surgic
biopsi
sampl
n
sensit
specif
serum
sampl
n
sensit
specif
rpa
show
minim
requir
sampl
prepar
multiplex
feasibl
henc
integr
assay
control
success
appli
rpa
test
despit
rpa
show
compar
clinic
perform
pcr
lamp
also
show
differ
unlik
lamp
softwar
avail
design
rpa
primer
probe
consequ
screen
sever
rpa
primer
probe
set
requir
choos
optim
combin
furthermor
verif
rpa
amplif
gel
electrophoresi
hamper
presenc
high
molecular
weight
protein
postamplif
purif
step
thu
requir
achiev
amplicon
gener
use
basic
fpg
kit
realtim
exo
kit
amplicon
degrad
exo
nucleas
although
pcr
requir
rapid
accur
temperatur
control
amplif
cycl
rpa
toler
temperatur
rang
without
lose
reaction
effici
allow
simplif
instrument
reduct
cost
portabl
userfriendli
instrument
adapt
rpa
reaction
exist
isotherm
devic
twistdx
realtim
fluoromet
exampl
portabl
batterypow
usd
devic
accommod
rpa
reaction
per
assay
monitor
fluoresc
channel
offer
magnet
mix
rpa
reaction
thu
enhanc
assay
sensit
similar
instrument
twistdx
support
reactionsassay
offer
magnet
mix
rpa
reaction
well
monitor
fluoresc
differ
channel
portabl
price
instrument
estim
usd
still
afford
compar
expens
thermocycl
usd
current
cost
rpa
reaction
estim
usd
twistdx
offer
custom
freezedri
servic
rpa
reaction
pellet
facilit
use
market
penetr
rpa
bring
rpa
step
closer
becom
true
poc
isotherm
molecular
assay
rpa
technolog
owe
speed
flexibl
complet
isotherm
profil
composit
protein
soup
mimic
part
vivo
recombin
process
show
exploit
mixtur
protein
n
known
biolog
function
reduc
instrument
cost
turnaround
time
molecular
diagnost
compar
number
protein
involv
perform
thermal
cycl
pcr
savant
mixtur
protein
enabl
isotherm
amplif
dna
rna
min
low
oper
temperatur
near
bodi
temperatur
rpa
minim
sampl
prepar
requir
known
toler
wide
rang
biolog
sampl
eg
serum
stool
urin
milk
nasal
vagin
plasma
food
plant
anim
tissu
led
develop
success
applic
technolog
differ
poc
sampletoansw
system
faster
bedsid
diagnost
although
rpa
test
platform
yet
clear
fda
ce
mark
think
right
time
rpa
emerg
clinic
laboratori
novel
costeffect
reliabl
isotherm
molecular
techniqu
author
contribut
author
confirm
contribut
intellectu
content
paper
met
follow
requir
signific
contribut
concept
design
acquisit
data
analysi
interpret
data
b
draft
revis
articl
intellectu
content
c
final
approv
publish
articl
